Search - tctmd.com

Displaying 21 - 40 of 421

Sort: Relevancy | Date

Presentation TCT 2023

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

Presenter: Andrew Sharp

October 25, 2023

Presentation TCT 2023

How to Perform rRDN (Medtronic) – Step by Step

Presenter: Tai Kobayashi

October 25, 2023

Presentation TCT 2023

How to Perform uRDN (Recor) – Step by Step

Presenter: Chandan Devireddy

October 25, 2023

Presentation TCT 2023

Clinical and Imaging Workup Prior to RDN

Presenter: Debbie Cohen

October 25, 2023

Presentation Miami Valves 2023

What’s New In Renal Denervation?

Presenter: Sergio Perez

February 04, 2023

Presentation Miami Valves 2023

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

Presenter: Mrudula R. Munagala

February 02, 2023

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

Presentation TCT 2022

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

Presenter: David John Kuraguntla

September 17, 2022

Presentation EuroPCR 2022

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Presenter: Felix Mahfoud

May 20, 2022

Presentation EuroPCR 2022

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Presenter: Ajay J. Kirtane, Michel Azizi

May 17, 2022

Presentation ARCH 2022

Current Status and Future of Renal Denervation for Hypertension

Presenter: Tim A. Fischell

April 23, 2022

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Presenter: Joost Daemen

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Presenter: Robert Schwartz

September 28, 2019

Advertisement

Debate – Most PCI Operators Should Be Able to Perform Renal Denervation (Pro)

How to Perform rRDN (Medtronic) – Step by Step

How to Perform uRDN (Recor) – Step by Step

Clinical and Imaging Workup Prior to RDN

What’s New In Renal Denervation?

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

Blood pressure and MACE reductions after renal denervation: 3-year GSR results

Patient-Level Pooled Analysis of Ultrasound RDN in RADIANCE-HTN SOLO and TRIO

Current Status and Future of Renal Denervation for Hypertension

TCT 677: Renal denervation in a young patient with malignant hypertension

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content